Hence, we examined the role of leptin and IL-6 signaling in HCC development, using mice with hepatic LEPR ablation and whole body IL-6Rα deficiency, which did not affect body composition and glucose homeostasis compared to control mice in the DEN-model. The gene discussed is IL6; the disease is hepatocellular carcinoma.